Navigation Links
New Jersey Health Foundation President Addresses Panel at AAHC Research Efficiency Conference
Date:1/8/2014

NEW BRUNSWICK, N.J., Jan. 8, 2014 /PRNewswire-USNewswire/ -- James M. Golubieski, president of New Jersey Health Foundation (NJHF) and Foundation Venture Capital Group (FVCG), discussed how these organizations promote the commercialization of research in New Jersey as he addressed a panel at the Research Efficiency Conference in Washington, DC, sponsored by the Association of Academic Health Centers.

At a session "Looking Beyond the NIH" that explored alternate funding sources, Mr. Golubieski discussed the unique model of New Jersey Health Foundation and Foundation Venture Capital Group and how they are helping scientists and universities to keep pace with a quickly moving research environment that has begun to emphasize commercialization as a means of advancing research.

"The fact that we are independent not-for-profit organizations allows us to invest in research at an early stage, providing start-up companies with the financial and strategic support they need to move their research to the next level," Mr. Golubieski explained to the group. 

New Jersey Health Foundation (www.njhf.org) is an independent organization supporting academic research and education programs at universities in New Jersey.  An investment of $10 million to fund its affiliate, Foundation Venture Capital Group (www.foundationventure.com), has allowed FVCG to invest in 10 start up companies with investments of up to $500,000 each.   One company was sold within 18 months at a substantial return on investment.  FVCG is currently selecting 10 more companies for investment.   

The Association of Academic Health Centers (www.aahcdc.org) is a non-profit organization that seeks to advance the nation's health and well-being through vigorous leadership of the nation's academic health centers.

"As economic pressures on research have intensified, the investments by funders like the New Jersey Health Foundation and Foundation Venture Capital Group add important viability to the overall research enterprise," said Dr. Steven A. Wartman, AAHC president and CEO.

In addition to Foundation Venture Capital Group, NJHF operates two other programs to support research in New Jersey.  Its Research Awards Program has granted more than $54 million to researchers in early stages of work since inception of the program.  A new program, Innovation Stage Funding Program, has awarded grants to researchers with promising ideas that may lead to developing patents or intellectual property.

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through its matching program, its Grants Program and its affiliate, Foundation Venture Capital Group (www.foundationventure.com) which makes private equity investments in life science start- up companies headed toward commercialization in New Jersey.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Custom Metal Fabricators of Stainless Steel Tanks and Components to Attend ISPE New Jersey Chapter 2013 Supplier Showcase and Tabletop Show
2. JTB Law Group, LLC Featured in New Jersey Legal Leaders, Top Rated Lawyers for 2013
3. Renowned New Jersey Plastic Surgeon Dr. Fred Coville Receives Prestigious Speaking Honor
4. Visiting Nurse Association of Northern New Jersey Announces Gardening Program at Friendship House Adult Day Care
5. Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013
6. Reproductive Medicine Associates of New Jersey Receives ACOG Prize for Paper on SET and CCS, a Pioneering IVF Process
7. Choose New Jersey and Partners to Promote New Jersey As Global Life Science Hub at Worlds Largest Biotechnology Event
8. Masy Systems Increases Validation Personnel in Pennsylvania and New Jersey
9. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
10. New Egg Donation Program, "Ovatures," Launched By Reproductive Medicine Associates Of New Jersey
11. Allergan Opens New Research and Development Center in Bridgewater, New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of ... Assay from Salimetrics’ SalivaLab , the relationship between insulin and other relevant ...
Breaking Biology Technology:
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):